| Debra S Clemmer, APRN | |
|
300 Flynn Ave, Burlington, VT 05401-5301 | |
| (802) 658-0400 | |
| Not Available |
| Full Name | Debra S Clemmer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 300 Flynn Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386673523 | NPI | - | NPPES |
| 0NS2001 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 10018427 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Debra S Clemmer, APRN 18 Clarke St, Unit 2, Burlington, VT 05401-3754 Ph: (802) 865-3616 | Debra S Clemmer, APRN 300 Flynn Ave, Burlington, VT 05401-5301 Ph: (802) 658-0400 |
News Archive
Texas Biomed scientists in San Antonio have found that moderate gum disease in an animal model exposed to an AIDS- like virus had more viral variants causing infection and greater in​flammation. Both of these features have potential negative implications in long term disease progression, including other kinds of infections, the researchers say in a new report.
Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, according to trial data reported in the February 24 online issue of the Journal of the National Cancer Institute.
In its review of the BLA, the FDA stated the T-DM1 trials did not meet the standard for accelerated approval because all available treatment choices approved for metastatic breast cancer, regardless of HER2 status, had not been exhausted in the study population.
Spyryx Biosciences, Inc., a privately-held biopharmaceutical company developing novel therapeutics for obstructive lung diseases, announced today it has received an award from Cystic Fibrosis Foundation Therapeutics, which will support development of Spyryx' therapeutic peptides for cystic fibrosis (CF).
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.
› Verified 7 days ago
Ms. Maureen Louise Dwyer, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Mcclure 5 Fletcherallen Healthcare, 111colchester Ave, Burlington, VT 05401 Phone: 802-847-2804 Fax: 802-847-2806 | |
Ms. Merja Cahoon, NNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2370 | |
Brooke Hopkins Ryba, MSN, RN, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Patricia Manion, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 Flynn Ave, Burlington, VT 05401 Phone: 802-488-6200 Fax: 802-488-6919 | |
Erin Michelle Leighton, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1205 North Ave, Burlington, VT 05408 Phone: 802-863-1313 | |
Kayleigh Martincic, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 128 Lakeside Ave, Burlington, VT 05401 Phone: 802-657-7000 | |
Mrs. Susan Albertini White, NURSE PRACTITIONER Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4589 |